Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system

Journal of Neurochemistry

Volumn 70, Issue 4, 1998, Pages 1584-1592

  Castano A ^a   Herrera, A J ^a   Cano, J ^a   Machado, A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Dopamine; Lipopolysaccharide; Microglia; Parkinson's disease; Rats; Substantia nigra

Indexed keywords

3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HOMOVANILLIC ACID; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; INFLAMMATION; INJECTION; MICROGLIA; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBSTANTIA NIGRA;

EID: 0031881687     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70041584.x     Document Type: Article

References (52)

1. Akiyama H. and McGeer P. L. (1989) Microglial response to 6-hydroxy-dopamine-induced substantia nigra lesions. Brain Res. 489, 247-253.
2. Alexi T. and Hefti F. (1993) Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture. Neuroscience 55, 903-918.
3. Andersson P. B., Perry V. H., and Gordon S. (1991) The kinetics and morphological characteristic of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 42, 201-214.
4. Andersson P. B., Perry V. H., and Gordon S. (1992a) Intracerebral injection of pro-inflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic recruitment to the parenchyma of the central nervous system. J. Exp. Med. 176, 255-259.
5. Andersson P. B., Perry V. H., and Gordon S. (1992b) The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48, 169-186.
6. Banati R. B., Gehrmann J., Schubert P., and Kreutzberg G. W. (1993) Cytotoxicity of microglia. Glia 7, 111-118.
7. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., and Hirsch E. C. (1994) Immunocytochemical analysis of tumor necrosis factor and its receptor in Parkinson's disease. Neurosci. Lett. 172, 151-154.
8. 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumor necrosis factor-a and lipopolysaccharide. Brain Res. 543, 194-200.
9. Bradbury A. J., Costall B., Domeney A. M., Jenner P., Kelly M. E., Marsden C. D., and Naylor R. J. (1986) 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Nature 319, 56-57.
10. Bronstein D. M., Perez-Otano I., Sun V., Mullis Sawin S. B., Chan J., Wu G.-C., Hudson P. M., Kong L.-Y., Hong J.-S., and McMillian M. K. (1995) Glia-dependent neurotoxicity and neuroprotection in mesencephalic culture. Brain Res. 704, 112-116.
11. Burrel R. (1990) Immunomodulation by bacterial endotoxin. Crit. Rev. Microbiol. 17, 188-208.
12. Castaño A., Herrera A. J., Cano J., and Machado A. (1993) Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat. Neuroscience 53, 179-185.
13. Castaño A., Lawson L. J., Fearn S., and Perry V. H. (1996) Activation and proliferation of murine microglia are insensitive to glucocorticoids in Wallerian degeneration. Eur. J. Neurosci. 8, 581-588.
14. Chao C. C., Hu S., Molitor T. W., Shaskan E. G., and Peterson P. K. (1992) Activated microglia mediate cell injury via a nitric oxide mechanism. J. Immunol. 149, 2736-2741.
15. +, a metabolite of MPTP, by brain synaptosomes. Biochem. Biophys. Res. Commun. 128, 1228-1232.
16. Compston A. (1992) Inflammation and the brain. Mol. Chem. Neuropathol. 19, 47-63.
17. Cruz C. J. and Beckstead M. (1989) Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra. Neuroscience 30, 331-338.
18. Di Monte D. A., Wu E. Y., and Langston J.W. (1992) Role of astrocytes in MPTP metabolism and toxicity. Ann. NY Acad. Sci. 648, 219-228.
19. G-nitroarginine in brain in vivo and in vitro. Biochem. Biophys. Res. Commun. 176, 1136-1141.
20. Elizan T. S. and Casals J. (1983) The viral hypothesis in parkinsonism. J. Neural Transm. Suppl. 19, 75-88.
21. Gibbs C. J. Jr. and Gajdusek D. C. (1982) An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism dementia and Parkinson's disease. Adv. Neurol. 36, 343-353.
22. Giulian D. (1993) Reactive glia as rivals in regulating neuronal survival. Glia 7, 102-110.
23. Giulian D., Vaca K., and Corpuz M. (1993) Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13, 29-37.
24. Jasso-López D. and Tapia R. (1995) Neurotoxic effect of intranigral injection of 1-methyl-4-phenylpyridinium on GABA-containing neurons and its relation to circling behavior. J. Neurochem. 64, 794-801.
25. Jeon B. S., Jackson-Lewis V., and Burke R. E. (1995) 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 4, 131-137.
26. Kristensson K. (1992) Potential role of viruses in neurodegeneration. Mol. Chem. Neuropathol. 16, 45-58.
27. Lawson L. J., Perry V. H., Dri P., and Gordon S. (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170.
28. Lawson L. J., Frost L., Risbridger J., Fearn S., and Perry V. H. (1994) Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve. J. Neurocytol. 23, 729-744.
29. Lee S. C., Liu W., Dickson D. W., Brosnan C. F., and Berman J. W. (1993) Cytokine production by human fetal microglia and astrocytes. J. Immunol. 150, 2659-2667.
30. Lees G. J. (1993) The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J. Neurol. Sci. 114, 119-122.
31. Liang S. M., Liang C. M., and Chiueh C. C. (1989) Visualization of interleukin-2-like molecules in MPP(+)-lesioned rat brain. Biochem. Biophys. Res. Commun. 165, 1312-1318.
32. Liu J. P. and Lauder J. M. (1992) S-100 beta and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro. J. Neurosci. Res. 33, 248-256.
33. Magal E., Burnham P., Varon S., and Louis J. C. (1993) Convergent regulation by ciliary neurotrophic factor and dopamine of tyrosine hydroxylase expression in cultures of rat substantia nigra. Neuroscience 52, 867-881.
34. Marini A. M., Schwartz J. P., and Kopin I. J. (1989) The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells. J. Neurosci. 9, 3665-3672.
35. McGeer P. L., Itagaki S., Akiyama H., and McGeer E. G. (1988a) Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol. 24, 574-576.
36. McGeer P. L., Itagaki S., Boyes B. E., and McGeer E. G. (1988b) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
37. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., and Nagatsu T. (1994a) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180, 147-150.
38. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., and Nagatsu T. (1994b) Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165, 208-210.
39. Mogi M., Harada M., Kondo T., Riederer P., and Nagatsu T. (1995) Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease. J. Neural Transm. Park. Dis. Dement. Sect. 9, 87-91.
40. Montero-Menei C. N., Sindji L., Pouplard-Barthelaix A., Jehan F., Denechaud L., and Darcy F. (1994) Lipopolysaccharide intracerebral administration induces minimal inflammatory reaction in rat brain. Brain Res. 653, 101-111.
41. Montero-Menei C. N., Sindji L., Garcion E., Mege M., Gamelin E., and Darcy F. (1996) Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia. Brain Res. 724, 55-66.
42. Murphy S., Simmons M. L., Agullo L., Feinstein D. L., Galea E., Reis D. J., Minc-Golomb D., and Schwartz J. P. (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16, 323-328.
43. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
44. Piani D., Frei K., Do K. D., Cuénod M., and Fontana A. (1991) Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett. 133, 159-162.
45. Poltorak M., Shimoda K., and Freed W. J. (1992) L1 substrate enhances outgrowth of tyrosine hydroxylase-immunoreactive neurites in mesencephalic cell culture. Exp. Neurol. 117, 176-184.
46. 3H]tyrosine by charcoal. Life Sci. 39, 2185-2189.
47. Rogers J., Civin W. H., Styren S. D., and McGeer P. L. (1992) Immune-related mechanisms of Alzheimer's disease pathogenesis, in Alzheimer's Disease, New Treatment Strategies (Khachaturian Z. S. and Blass J. P., eds), pp. 147-163. Marcel Dekker, New York.
48. +-induced cell injury in the striatum of rats. Br. J. Pharmacol. 111, 837-842.
49. Sawada H., Kawamura T., Shimohama S., Akaike A., and Kimura J. (1996) Different mechanisms of glutamate-induced neuronal death between dopaminergic and non-dopaminergic neurons in rat mesencephalic culture. J. Neurosci. Res. 43, 503-510.
50. Schaar D. G., Sieber B. A., Dreyfus C. F., and Black I. B. (1993) Regional and cell-specific expression of GDNF in rat brain. Exp. Neurol. 124, 368-371.
51. Szczepanik A. M., Fishkin D. K., Rush D. K., and Wilmot C. A. (1996) Effects of chronic intrahippocampal infusion of lipopolysaccharide in the rat. Neuroscience 70, 57-65.
52. Venero J. L., Revuelta M., Cano J., and Machado A. (1997) Time course changes in the dopaminergic nigrostriatal system following transection of the medial forebrain bundle: detection of oxidatively modified proteins in substantia nigra. J. Neurochem. 68, 2458-2468.